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The intestinal microbiota plays an important role in modulation of mucosal immune responses. To seek interactions between
intestinal epithelial cells (IEC) and commensal bacteria, we screened 49 commensal strains for their capacity to modulate NF-
κB. We used HT-29/kb-seap-25 and Caco-2/kb-seap-7 intestinal epithelial cells and monocyte-like THP-1 blue reporter cells to
measure eﬀects of commensal bacteria on cellular expression of a reporter system for NF-κB. Bacteria conditioned media (CM)
were tested aloneortogether withan activator of NF-κB to explore its inhibitory potentials. CM from 8 or 10 diﬀerent commensal
species activated NF-κB expression on HT-29 and Caco-2 cells, respectively. On THP-1, CM from all but 5 commensal strains
stimulatedNF-κB. Upon challenge withTNF-α orIL-1β,s o m eC Mp r e v e n t e di n d u c e dN F - κB activation, whereas others enhanced
it. Interestingly, the enhancing eﬀect of some CM was correlated with the presence of butyrate and propionate. Characterization
of the eﬀects of the identiﬁed bacteria and their implications in human health awaits further investigations.
1.Introduction
The adult human gut is populated with a large number of
commensal bacteria known to inﬂuence many aspects of the
host gut physiology, including immunity, development, and
homeostasis. There is considerable clinical and experimental
evidence showing that commensal gut bacteria contribute
to immune homeostasis by altering microbial balance or by
interacting with the gut immune system [1]. However, cellu-
larandmolecularmechanisms by which individual members
of the commensal microbiota contribute to immune home-
ostasis have not been completely elucidated.
Intestinal epithelial cells (IEC) are the ﬁrst point of
contact for bacteria within the gut lumen, and they interact
with the gut immune system. Consequently, IEC have a
pivotal function in bacteria-host communication. Bacterial
signatures generally activate signaling cascades that can
trigger proinﬂammatory gene transcription through speciﬁc
receptors (e.g., Toll-like receptors) expressed on apical and/
or basolateral surface of epithelial cells. This mechanism
is largely controlled by the transcriptional factor NF-κB
[2]. NF-κB is a dimeric DNA binding protein whose major
form is represented by the association of p65 and p50
proteins. In steady state, NF-κB is locked in the cytoplasm
by an inhibitory protein of the IκB family. Upon receptor
activation, IκB is phosphorylated by the IκBk i n a s ec o m p l e x
(IKK) before undergoing degradation by the proteasome.
Then, freeNF-κBtranslocate tothenucleustoturnonalarge
number of genes involved in proinﬂammatory processes at
the site of infection or tissue damage.
Obviously, the intestinal epithelium does not trig-
ger inﬂammatory responses against commensal bacteria.
Interestingly, the mechanisms allowing commensal micro-
organisms to be tolerated by the intestinal mucosa are
far from being completely understood. Numerous studies
have suggested an involvement of active processes causing2 Journal of Biomedicine and Biotechnology
a functional downregulation of the inﬂammatory response
that is generally obtained by interference with the NF-κB
pathway.Indeed, previousreports showed the suppressionof
inﬂammatory responses inepithelialcellsbycommensalbac-
teria either through direct interaction leading to alteration
in Toll-like receptors (TLRs) signaling to NF-κB[ 3, 4]o r
through direct inhibition of NF-κB transcriptional activity
[5]. In addition, some secreted bacterial factors resulting
from commensals or probiotics activity have been found to
exert anti-inﬂammatory eﬀects on IEC [6–10].
Furthermore, recent work has ascribed a critical role for
NF-κB signaling in maintenance of homeostatic immuno-
inﬂammatory function in the gut [11]. Indeed epithelial
NF-κB preserves integrity of the gut epithelial barrier and
coordinates antimicrobial actions of the innate and adaptive
immunesystems. Accordingly,bothdeﬁciencyin,and hyper-
activation of, this transcription factor are underlying factors
in chronic inﬂammatory bowel diseases [12–16].
Finally, determining the microbial factors that positively
or negatively regulate this key pathway is of great clinical and
scientiﬁc interest. Thus, in the present study, we examined
the eﬀect of 49 commensal bacteria on the modulation of
NF-κB pathway in human IEC models bearing a stable NF-
κB-SEAP reporter system. Conditioned media (CM) from
thesebacteriaweretestedeitheraloneorincombinationwith
an activator of NF-κB signaling (TNF-α or IL-1β)t oi d e n t i f y
itsinhibitory andenhancingpotentials.Tocompareresponse
proﬁles between IEC and immune cells, all CM were also
tested on human monocyte cell line THP-1 bearing the same
NF-κB reporter system.
2.MaterialandMethods
2.1. Cell Culture and Reagents. HT-29 cells were grown in
DMEM (Sigma) with 2mM L-glutamine, 50IU/mL peni-
cillin, 50μg/mL streptomycin and 10% heat-inactivated fetal
calfserum(FCS-Lonza)inahumidiﬁed5%CO2 atmosphere
at 37◦C. Caco-2 were cultured in DMEM (Sigma) supple-
mented withthe same amounts ofglutamineand antibiotics,
20% heat-inactivated FCS and 1x nonessential amino acids
(Invitrogen). The THP-1 blue CD14+ NF-κB reporter clone
w a so b t a i n e df r o mI n v i v o g e na n du s e da c c o r d i n gt ot h e
manufacturer’s instruction.
2.2. Commensal Strains and Preparation of Conditioned
Media. The 49 commensal strains were grown in anaerobic
condition at 37◦C using the Hungate culture method [17].
Screened strains and corresponding growth media are listed
in Table 1.
At the end of the incubation period, bacterial cultures
were centrifuged at 5,000xg for 10 minutes. Bacteria con-
ditioned media (CM) were then collected and ﬁltered on
0.2μm PES ﬁlters. Noninoculated bacteria culture medium
served as control.
2.3. Analyses of NF-κB Activation—SEAP Reporter Assay.
Construction and validation of the NF-κB reporter clones
HT-29/kb-seap-25 and Caco-2/kb-seap-7 have been des-
cribed previously [18]. For each experiment, Caco-2/kb-
seap-7 and HT-29/kb-seap-25 reporter clones were seeded at
50,000 cells per well, into 96-wells plates and incubated 24
hours. Then, cells were stimulated for 24 hours with 10μLo f
each tested bacteria CM, for a ﬁnal volumeof100μLp e rw e l l
(i.e., 10% vol/vol), in the presence or absence of TNF-α or
IL-1β (10ng/mL ﬁnal, for HT-29 and Caco-2, resp.).
THP-1reportercellswereseededat100,000cellsperwell,
into 96-wells plates and stimulated with 10% (vol/vol) of
each tested bacteria CM. Cells were then incubated 24 hours
prior to quantiﬁcation of alkaline phosphatase (SEAP).
SEAP in the supernatant was revealed using the Quanti-
Blue reagent (Invivogen) according to the manufacturer’s
protocol and quantiﬁed at 655nm OD. All measurements
were performed using a microplate reader (Inﬁnite 200,
Tecan).
2.4. Statistical Analysis. Results are expressed as mean ± SD.
Data were analyzed using Student’s t test.
3.Results
3.1. Eﬀect of Bacteria CM on NF-κB Activation in IEC and
Monocyte Models. O u to f4 9b a c t e r i aC M ,8a n d1 0C M
signiﬁcantly activated the NF-κB reporter system on HT-
29 and Caco-2 reporter cells, respectively (Figures 1(a) and
1(b)). In fact, the 2 cell lines were largely unresponsive
to the vast majority of the tested bacteria CM. Active
bacteria CM identiﬁed on both epithelial cells belonged to
Clostridium sardiniensis, Selenomonas ruminantium, Rose-
buria hominis, Roseburia intestinalis, Butyrivibrio ﬁbrisolvens,
Roseburia faecis,a n dFaecalibacterium prausnitzii. Bacteroides
uniformis activated NF-κB only on HT-29/kb-seap-25, while
a small, nonsigniﬁcant stimulation was observed on Caco-
2( P>. 05). Clostridium paraputriﬁcum and Parabacteroides
distasonis induced NF-κB activation speciﬁcally in Caco-
2/kb-seap-7.Althoughstatisticallysigniﬁcant,theseobserved
stimulations were lower than the oneobserved with IL-1β on
Caco-2/kb-seap-7cells(mean 1.03 ±0.17)orwithTNF-αon
HT-29/kb-seap-25 (mean 0.92 ± 0.18).
Conversely, almost all bacteria CM activated NF-κBo n
THP-1 blue reporter cells except those from Ruminococcus
gnavus, Ruminococcus obeum,a n dRuminococcus lactaris
(Figure 1(c)). Stimulation levels measured in HT-29 and
Caco-2 were weak in comparison to those obtained in THP-
1. Lipopolysaccharide (LPS) used as control in THP-1 cells
showed a lower stimulatory eﬀect than most activating CM
(mean 0.38 ± 0.13).
3.2. Eﬀect of Bacteria CM on Activated NF-κB in IEC. In
order to explore the inhibitory and/or enhancing poten-
tials of commensal bacteria CM on NF-κBa c t i v a t i o n ,
cotreatment with the proinﬂammatory cytokines TNF-α
(10ng/mL) or IL-1β (10ng/mL) was performed on HT-29
and Caco-2, respectively (Figure 2). The positive control
of NF-κB activation was noninoculated bacteria culture
medium combined with the stimulatory cytokine. The valueJournal of Biomedicine and Biotechnology 3
Table 1: Bacteria strains, references, and growth media.
Designation Collection reference Medium Phylum
Atopobium parvulum DSM 20649T M104 A
Biﬁdobacterium adolescentis ATCC 15703 M58 A
Biﬁdobacterium angulatum ATCC 27535-CIP 104167 M58 A
Biﬁdobacterium animalis ssp. animalis DSM 20104 M58 A
Biﬁdobacterium biﬁdum DSM20082/JCM1254 M58 A
Biﬁdobacterium breve 1 DSMZ 20091 M104 A
Biﬁdobacterium breve 2 ATCC 15701-89/23 M104 A
Biﬁdobacterium catenulatum ATCC27539-CIP104175 M58 A
Biﬁdobacterium choerinum DSM 20434 M58 A
Biﬁdobacterium dentium 1 ATCC 15423 M104 A
Biﬁdobacterium dentium 2 ATCC 27534-89/20 M104 A
Biﬁdobacterium gallicum ATCC 49850-CIP 103417 M58 A
Biﬁdobacterium infantis DSM20088/ATCC15697 M58 A
Biﬁdobacterium longum ATCC 15707-NCTC 11818 M58 A
Biﬁdobacterium pseudocatenulatum DSM 20438-ATCC 27919 M58 A
Biﬁdobacterium ruminantium ATCC 49390 M58 A
Collinsella aerofaciens ATCC 25986 BHI∗∗ A
Propionibacterium acnes B15 M104 A
Bacteroides caecae ATCC 43185-CIP 104201T BHI B
Bacteroides dorei DSM 17855 M104 B
Bacteroides fragilis B6-AL 2553 BHI B
Bacteroides ovatus ATCC 8483-CIP103756 M104 B
Bacteroides thetaiotaomicron ATCC 29148-VPI5482 M104 B
Bacteroides uniformis ATCC 8492 M104 B
Bacteroides vulgatus ATCC 8482-CIP 103714 BHI B
Parabacteroides distasonis CIP104284-ATCC8503 BHI B
Parabacteroides johnsonii DSM 18315 M104 B
Prevotella copri DSM 18205 M104 B
Blautia/Clostridium coccoides ATCC 2936 BHI F
Blautia producta/Ruminococcus productus DSMZ 2950-92/46 M104 F
Blautia/Ruminococcus hansenii DSM 20583 M104 F
Butyrivibrio ﬁbrisolvens DSM3071 BHI F
Clostridium leptum ATCC29065-DSM753 BHI F
Clostridium nexile 96/2 ATCC 27757-DSM 1787 BHI F
Clostridium paraputriﬁcum G12PR-X73445 BHI F
Clostridium sardiniensis I11PR M78 F
Clostridium sordellii ATCC 9714 BHI F
Clostridium sporosphaeroides ATCC 25781 M78 F
Dorea/Eubacterium formicigenerans ATCC 27755 L-DON∗ F
Eubacterium rectale ATCC 33656-CIP105953 BHI F
Faecalibacterium prausnitzii L2-6 (Duncan) BHI F
Roseburia faecis DSM 16840 BHI F
Roseburia hominis DSM 16839 M58 F
Roseburia intestinalis DSM 14610 M58 F
Ruminococcus gnavus FRE1 L-DON F
Ruminococcus lactaris ATCC 29176 L-DON F
Ruminococcus obeum ATCC 29174 L-DON F
Ruminococcus torques ATCC 27756 M104 F
Selenomonas ruminantium ATCC19205-DSM2872 L-DON F
∗Yeast extract-CaCl2—sodium thioglycholate—pyruvic acid.
∗∗Brain heart infusion + yeast extract and hemine.
A: Actinobacteria; B: Bacteroidetes; F: Firmicutes.4 Journal of Biomedicine and Biotechnology
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Figure 1: Comparisonof the stimulatory eﬀect of 49 commensalbacteria conditioned media on HT-29/kb-seap-25, Caco-2/kb-seap-7, and
THP-1-blue. NF-κB activity is expressed as OD 655nm. Data are presented as mean +/− SD of 3 independent experiments performed in
HT-29 (a) and Caco-2 (b) and of 2 independent experiments performed in THP-1 (c). Control is noninoculated bacteria medium and its
activity was normalized to 0 (represented by the X-axis). ∗P<. 05 compared to control. For THP-1 only: ns: not signiﬁcant.All other values
are signiﬁcantly diﬀerent from control (P<. 05).Journal of Biomedicine and Biotechnology 5
Atopobium parvulum 
Biﬁdobacterium adolescentis 
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Ruminococcus torques  
Selenomonas ruminantium 
Strain HT-29 Caco-2
+5.8( 0 .374) −6.1( 0 .233)
+27.4( 0 .067) −39.3( 0 .048)
+23.9( 0 .095) −41 (0.046)
+27.5( 0 .056) −23.5( 0 .041)
+28 (0.063) −32.6( 0 .06)
+39.5( 0 .035) +0.8( 0 .464)
+4.7( 0 .389) −9.3( 0 .151)
+37.3( 0 .03) −20.7( 0 .107)
+40.9( 0 .022) −20 (0.179)
+18.1( 0 .144) −13.1( 0 .1)
+15 (0.212) −21 (0.046)
+37 (0.034) −8.8( 0 .114)
+24.9( 0 .081) −21.5( 0 .038)
+25.3( 0 .067) −28.8( 0 .044)
+16.4( 0 .203) −42 (0.081)
+21.1( 0 .093) −24.9( 0 .073)
−14.1( 0 .081) −17.1( 0 .027)
+23.7( 0 .104) −0.8( 0 .461)
+11 (0.152) −12.6( 0 .054)
+8.3( 0 .306) −12.1( 0 .106)
+18.6( 0 .043) +3.4( 0 .322)
+10.8( 0 .247) −9.6( 0 .167)
+11 (0.24) −2.5( 0 .275)
+110.2( 0 .002) +43.5( 0 .016)
+14.4( 0 .120) −16.4( 0 .029)
+22.4( 0 .065) +0.6( 0 .467)
+16.8( 0 .173) −5.5( 0 .290)
+7.2( 0 .326) −15.8( 0 .066)
+11.6( 0 .088) −13.3( 0 .049)
+7.2( 0 .322) −11.5( 0 .149)
+14.2( 0 .210) −18.2( 0 .057)
+3.5( 0 .331) −13.5( 0 .052)
−10.4( 0 .137) −16.9( 0 .03)
−0.4( 0 .475) −20 (0.017)
+8.6( 0 .139) +17.8( 0 .055)
+45.3( 0 .02) +51.6( 0 .001)
−20.9( 0 .035) −8.4( 0 .118)
+42.9(0.008) +45.8( 0 .0004)
+14.1( 0 .091) −1( 0 .337)
−3.5( 0 .333) −14.8( 0 .042)
+33.5( 0 .012) +10 (0.104)
+42.2( 0 .003) +34.5( 0 .025)
+51 (0.016) +37.9( 0 .002)
+61.2( 0 .009) +45.6( 0 .009)
−1.7( 0 .435) −5.2( 0 .120)
+5.1( 0 .250) +0.6( 0 .382)
+3.3( 0 .342) −1.5( 0 .275)
−4.1( 0 .411) −11.4( 0 .116)
+21.6( 0 .02) −6.3( 0 .194)
(a)
Color code No signiﬁcant eﬀect
Inhibitory with P value <. 1
Inhibitory with P value <. 05
Stimulatory with P value <. 1
Stimulatory with P value <. 05
(b)
Figure2:(a)EﬀectofbacteriaCMonactivated NF-κBinHT-29andCaco-2reporter cells.NF-κB activity isexpressed asarelativepercentage
compared to the positive control (normalized to 0). Positive controls are cells treated with noninoculated bacteria culture medium and the
stimulatory cytokine. The corresponding P value is indicated in parenthesis and inhibitory and stimulatory strains are identiﬁed following
the color code shownin (b).
of NF-κB activity measured for the positive control was
normalized to 0. The values obtained for each strain were
expressed as percentage of activation relative to that of the
positive control. For example, Selenomonas ruminantium
CM combined with TNF-α induced NF-κB activity 21.6%
higher than the one obtained with the positive control
(i.e., noninoculated bacteria medium combined with TNF-
α).6 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of SCFA and organic acids on NF-κBa c t i v a t i o n .
HT-29 cells were treated with acetic, butyric, propionic, lactic,
succinic,andformicacidseitheraloneorincombinationwithTNF-
α (10ng/mL) for 24 hours. Results are expressed as OD 655nm.
Data is representative of 1 experiment out of 3 performed. ∗P<. 05
compared to TNF control.
Adiﬀerentbehaviorofthe2epithelialmodelsinresponse
tothebacteria CMcouldalsobe observed(Figure 2). Indeed
onHT-29,CMoverallenhancedNF-κBacti vitym or ethanin
Caco-2. Interestingly, a large majority of Biﬁdobacteria CM
were stimulatory on HT-29 while inhibitory on Caco-2.
Some bacteria CM had a similar eﬀect on the 2 reporter
cells (Figure 2). Induced NF-κB activation was restrained in
the 2 cell lines only by Colinsella aerofasciens, with inhibition
rates of 14.1% (P = .081) and 17.1% (P = .027) for
HT-29 and Caco-2, respectively. Furthermore, the 3 species
of Roseburia as well as Clostridium sardiniensis, Clostridium
sporosphareoides,a n dBacteroides uniformis enhanced NF-κB
activation signiﬁcantly in both cell lines.
We also observed that some CM had eﬀects only on
one reporter cell line such as CM from Selenomonas ru-
minantium, Faecalibacterium prauznitzii, Bacteroides frag-
ilis, Parabacteroides distasonis,a n dBiﬁdobacterium breve 1.
These CM increased NF-κB activity in HT-29/kb-seap-25
but exhibited nonsigniﬁcant eﬀects on Caco-2/kb-seap-7.
Similarly, Eubacterium rectale, Clostridium nexile 96/2, Clo-
stridium leptum, Blautia coccoides,a n dBacteroides vulgatus
exerted signiﬁcant inhibitory eﬀects only on Caco-2.
3.3. Eﬀect of Short Chain Fatty and Organic Acids on NF-
κB Activation in IEC. Commensal bacteria are known to
produceapanelofacidsduringtheirmetabolicactivity,espe-
cially short chain fatty acid (SCFA), which could interfere
with NF-κB response.
Therefore, we evaluated the eﬀects of acetic, butyric,
propionic,lactic,succinic,andformicacidsonNF-κBinIEC,
either alone or on cytokine-activated cells (Figure 3). The
results presented were obtained on HT-29 although similar
observations were performed on Caco-2 (data not shown).
None ofthe acids had an eﬀectonHT-29orCaco-2when
used alone. However, butyrate and propionate produced
a dose-dependent hyperactivation of NF-κBo nT N F - α
activated cell. The other acids induced a small but signiﬁcant
stimulatory eﬀectonly atthehighest concentration(6–8mM
ﬁnal) and a very small but yet signiﬁcant inhibitory eﬀect
of NF-κB at the lowest concentrations. Since butyrate and
propionate are likely to act on activated NF-κB signaling, we
quantiﬁed SCFA in the CM by HPLC and examined their
associations with NF-κB activity. We found that out of 49
bacteria CM, 19 contained butyrate, propionate, or both
(Figure 4).
Figure 4 represents a plot of the amount of butyrate
(Figure 4(a)) or propionate (Figure 4(b))p r e s e n ti ne a c h
bacteria CM (X-axis) with the NF-κBa c t i v i t ym e a s u r e di n
HT-29 in response to cotreatment with bacteria CM and
TNF-α (see Figure 2). A Spearman correlation test was
performed by taking into account butyrate and propionate
concentrations greater than 1mM. A signiﬁcant positive
correlation (r = 0.76, P = .036) was observed between
butyrate concentration and NF-κB activity, suggesting that
the butyrate-producing strains might have exerted their
stimulatory eﬀect through the butyrate released during
growth.Similarly,mostofthepropionate-producingbacteria
were also stimulatory on HT-29, but the correlation between
propionate concentration and NF-κBa c t i v i t yw a sn o ts i g n i f -
icant (r = 0.49, P = .075). However, the correlation became
highly signiﬁcant when only strains from the Bacteroidetes
phylum (r = 0.81, P = .005) were included in the
analyses.This suggeststhattheeﬀectoftheotherpropionate-
producing strains might be due to other active metabolites
that are diﬀerent from propionate.
4.Discussion
In this study, we aimed at identifying commensal strains
deemed capable of regulating eukaryotic cell signaling focus-
ingontheNF-κBsignaling pathway,which is largelyinvolved
in immune and inﬂammatory responses.
In the IEC models HT-29 and Caco-2, the majority
of bacteria CM had no eﬀect on NF-κB, contrasting with
the results obtained with the monocyte cell line THP-
1. This observation may be explained by the diﬀerencesJournal of Biomedicine and Biotechnology 7
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Figure 4: Correlation between butyrate or propionate concen-
tration of the bacteria CM and NF-κBa c t i v i t y .N F - κBa c t i v i t y
measured in HT-29 in response to cotreatment with bacteria CM
and TNF-α (10ng/mL) based on the amount of butyrate (a) and
propionate (b) present in each bacteria CM. NF-κBa c t i v i t yi s
expressed as a relative percentage (values from Figure 2). Butyrate
and propionate amounts were determined by HPLC and expressed
inmM.A Spearmancorrelation test wasperformed: Butyrate versus
NF-κBa c t i v i t y :r = 0.76 (P = .036). Propionate versus NF-κB
activity: r = 0.49(P = .075).Propionate(Bacteroidetes only)versus
NF-κBa c t i v i t y :r = 0.81 (P = .005).
in the expression of receptors specialized in recognition
of microbial structures, especially TLRs. Indeed, THP-1
reporter clone as well as the parental cell line express a
complete range of TLRs and all ﬁve surface TLRs (TLR1/2,
TLR2, TLR6/2, TLR4, and TLR5) are present and functional
[18–20], resulting in increased sensitivity to a wide range
of microbe-associated molecular patterns. Conversely, HT-
29 and Caco-2 do not express all TLRs. Parental HT-29
cell line as well as the reporter clone HT-29/kb-seap-25
mainly express a functional TLR5, which is responsible for
detection of ﬂagellin [21]. Caco-2 parental cell line was also
described to be responsive to TLR5 stimulation [22, 23],
but the reporter clone Caco-2/kb-seap-7 that was obtained
and used throughout our study is poorly sensitive [18].
In addition, unresponsiveness toward stimulation of other
TLRs such as TLR2 and TLR4 was reported for parental
intestinal epithelial cell lines [24–26]a n dw a sa l s oo b s e r v e d
with our IEC reporter clones [18].
Furthermore, the fact that HT-29/kb-seap-25 is sensitive
to ﬂagellin explains the basal stimulatory eﬀect displayed by
theCMfrom ﬂagellatedcommensal strains suchas Roseburia
spp., Selenomonas ruminantium and Butyrivibrio ﬁbrisolvens
[27–29]. These ﬂagellated commensals also stimulated NF-
κB in Caco-2/kb-seap-7, but these cells are less sensitive
to ﬂagellin than HT-29 which explains the weak response
obtained. Stimulation by Bacteroides uniformis and Faecal-
ibacterium prausnitzii CM on both cell lines was not likely
due to a putative ﬂagellin expression since these bacteria are
not motile [30, 31] ,w h i c hi sn o tt h ec a s ew i t hClostridium
sardiniensis [32].
Clostridium paraputriﬁcum, Parabacteroides distasonis,
and Biﬁdobacterium breve 1 CM stimulated Caco-2 but not
HT-29, supporting the assertion that the eﬀect is indepen-
dent ofTLR5 recognition. SinceCaco-2 reporter cells are not
sensitive to TLRs stimulation [18], the speciﬁc stimulatory
eﬀect of these 3 bacteria CM need further evaluation. In
addition, the lack of response of THP-1 toward CM from 3
diﬀerentstrains ofRuminococcusis an intriguing observation
that also deserves attention.
The 2 reporter cells used in this study were stimulated by
the commensal bacteria CM combined with a known NF-κB
activator. This challenge was performed in order to identify
both the stimulatory as well as the inhibitory contributors of
NF-κB signaling activity. The 2 proinﬂammatory cytokines
TNF-α and IL-1β were used to activate NF-κBo nH T - 2 9a n d
Caco-2, respectively, [18]. Under these conditions, some CM
remarkably dampened NF-κB activation in these cells with
the inhibition occurring mainly in IL-1β-activated Caco-2.
Several Biﬁdobacterium strains were described for their
capacity to dampen NF-κBa c t i v a t i o nin vitro in diﬀerent cell
models, including Caco-2 and HT-29 [33, 34]. Consistent
with this, few Biﬁdobacterium CM reduced NF-κBa c t i v a t i o n
on Caco-2, but were ineﬀective on HT-29. In contrast, in
thepresent study,CMfromBiﬁdobacterium strains enhanced
NF-κB activation by TNF on HT-29. However, in our study,
we measured the transcriptional activity of NF-κBi n s t e a do f
theproductofonegenecontrolledbyNF-κB.Itiswellknown
that NF-κB controls the activation of several genes not
only involved in inﬂammatory processes, but also in tissue
protection and homeostasis. For example, production of
human β-defensin in IEC, which is NF-κB-dependent [35],
is stimulated by probiotics, including the Biﬁdobacterium-
containing mixture VSL#3 [36].Obviously, this dualeﬀectof
Biﬁdobacterium strains on NF-κB signaling requires further
examination.
Butyrate (or butyric acid) and propionate, 2 products of
bacterial fermentation, enhanced NF-κB activation induced
by TNF-α or IL-1β in our reporter cells. As such, butyrate-
producing bacteria stimulated NF-κBa c t i v i t ya n das t r o n g
correlation has been found between bacteria CM butyrate
concentration and NF-κBa c t i v i t y .
However some propionate-producing bacteria, such as
Eubacterium rectale and Clostridium leptum did not enhance
NF-κB, suggesting the existence of other metabolites that
maycounterthestimulatoryeﬀectofpropionateonactivated
epithelial cells.
It is noteworthy that although butyrate is classically
known for preventing NF-κBa c t i v a t i o ni nI E C[ 37–39],
some recent studies suggest that butyrate also promotes
NF-κB transcriptional activity in IEC [40, 41]. In addition,
butyrate has been shown to promote human β-defensin
expression, whose gene transcription is controlled by NF-κB
[42].8 Journal of Biomedicine and Biotechnology
5.Conclusion
The mechanisms underlying the inhibitory and stimulatory
eﬀects of NF-κB signaling in monocyte and IEC models by
nonbutyrate-producing and nonﬂagellated bacteria strains
remain to be explored. The cell-based screening method
employedin the present study provides a rapid identiﬁcation
of potentially interesting commensal species; however, their
eﬀects require further conﬁrmation and characterization
using other techniques of NF-κB detection. Moreover, the
potential implication of these commensal bacteria and their
host cells regulating properties in human health and disease
may need to be evaluated.
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